{"id":"NCT00526097","sponsor":"Boehringer Ingelheim","briefTitle":"Dulcolax vs Placebo in Functional Constipation","officialTitle":"A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of 4 Weeks Treatment With Bisacodyl (Dulcolax) Tablets 10mg Administered Orally, Once Daily, in Patients With Functional Constipation.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-09","primaryCompletion":"2009-06","completion":null,"firstPosted":"2007-09-06","resultsPosted":"2010-08-06","lastUpdate":"2014-01-15"},"enrollment":368,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Constipation"],"interventions":[{"type":"DRUG","name":"Bisacodyl 10 mg","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Bisacodyl 5 mg x 2 once daily","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of the study was to compare the efficacy and safety of 4 weeks treatment with bisacodyl (Dulcolax) tablets 10 mg to placebo in patients with functional constipation. In addition, the effect of treatment on quality of life and general health status was evaluated.","primaryOutcome":{"measure":"Mean Number of Complete Spontaneous Bowel Movements (CSBMs) Per Week Over the 4 Weeks Treatment Period","timeFrame":"4 Weeks","effectByArm":[{"arm":"Placebo","deltaMin":1.9,"sd":0.34},{"arm":"Bisacodyl","deltaMin":5.2,"sd":0.27}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":27,"countries":["United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":121},"commonTop":["Diarrhoea","Abdominal pain","Abdominal pain upper","Headache"]}}